Society of Surgical Oncology

In the Evidence Today and Tomorrow series, the SSO HPB Disease Site Working Group discusses the latest in hepatocellular carcinoma. Join Drs. Hallet, Lo, Yopp, Singal, and Kelley as they highlight evidence and future trials shaping HPB surgical oncology. ow.ly/TxI450Wrmx9

New weekly@AnnSurgOncol featured the article: National Guidelines for Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Peritoneal Malignancies: A Worldwide Systematic Review and Recommendations of Strength Analysis. ow.ly/1nBQ50WvjNK

SSO invites cancer care professionals to submit abstracts for #SSO2026, taking place March 5–7, 2026, in Phoenix. Showcase your research, clinical advancements, or surgical techniques to an audience of surgical oncology leaders. Submit now: ow.ly/wKVm50WqxEY

New weekly @AnnSurgOnco featured the article — Practical Approaches to High-Risk Anastomoses in Robotic Pancreatoduodenectomy: surgonc.org/annals-of-surg… #ASOFeaturedArticle

📣 The Society of Surgical Oncology is now on Instagram! Follow us for member highlights, event updates, resources, and more: 👉ow.ly/H9hy50WtrhQ

From the July Issue of @AnnSurgOncol: Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2− Locally Advanced #BreastCancer rdcu.be/exHRu @DrJamesJakub @SyedAAhmad5

Advance your research by applying for an SSO Clinical Investigator or Young Investigator Award! SSO is accepting proposals for both awards. Learn more about the awards, criteria, deadlines, and how to apply: ow.ly/CLTc50WuVi7

From the July Issue of @AnnSurgOncol: National Variation in Implementation of #SentinelLymphNodeBiopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy rdcu.be/exy2Q @EdiBonci @SyedAAhmad5

From the July Issue of @AnnSurgOncol: Cartilage Resection in the Surgical Management of Ear #Melanoma rdcu.be/exozc @jeffreyfarma @SyedAAhmad5

Register for the next SSO webinar! 👇 Explore treatment strategies for colorectal and appendiceal cancers, including systemic therapy, cytoreductive surgery, and HIPEC. Save your spot now: ow.ly/yMit50WnIE6

You are encouraged to nominate yourself or another member for one of several open leadership positions in the 2026 election cycle. This year’s process has been simplified to encourage broad participation. Check your inbox for more details.

Our first SurgOnc Academy Micro-Learning is live! Explore “Neoadjuvant-Adjuvant Pembrolizumab in Stage IIB/C Melanoma” — a quick dive into a recent clinical trial on checkpoint inhibitor therapy. Explore now: ow.ly/TbWM50WrxBq

Share your expertise at #ACT2026! The submission deadline is Monday, October 20. Plus, when you submit an abstract, your confirmation email will include a promo code to waive the abstract submission fee for SSO 2026! Submit now: ow.ly/yecn50WqxYW

From the July Issue of @AnnSurgOncol — Undergoing #CytoreductiveSurgery for Colorectal #PeritonealMetastases : A Qualitative Exploration of the Lived Experiences of Patients and Carers rdcu.be/exd8d @DavidCabaMD @SyedAAhmad5

Listen now in the ASO Article Series: Dr. Rick Greene and Dr. Eduardo Vega discuss predictors of futile surgery in gallbladder cancer—and how a new model can help optimize patient selection. Based on "Optimizing Outcomes in Gallbladder Cancer." ow.ly/eBu850WqBgL

⏰Reminder: The deadline to apply for SSO’s 2026 mentorship programs is Wednesday, July 23! Whether you're just starting or ready to lead, there's a program designed to support your growth in surgical oncology. Don’t miss out: ow.ly/tyXH50WnbCT

From the July Issue of @AnnSurgOncol: Laparoscopic Minimally Invasive Approach for Pelvic Solitary #FibrousTumor rdcu.be/ewR8B @DorianGarciaMD @SyedAAhmad5

New weekly Annals of Surgical Oncology featured the article — Improving Urothelial Carcinoma Outcomes: The Powerful Combination of Neoadjuvant and Adjuvant Chemotherapy in the Perioperative Period: ow.ly/OXL550WrV70